A Randomized Prospective Multicenter Trial of Belotecan/Cisplatin Versus Etoposide/Cisplatin in Patients With Previously Untreated, Extensive-Stage Small-Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Belotecan (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms COMBAT
- 30 Oct 2013 Primary endpoint 'Objective-clinical-response-rate' has been met.
- 30 Oct 2013 Status changed from recruiting to completed.
- 02 Oct 2012 Interim results presented at the 37th Congress of the European Society for Medical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History